SEC Form 4 · accession 0001209191-15-072877
MEDIVATION, INC. · MDVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mohammad Hirmand
Officer — Interim Chief Medical Officer
Period of report
Sep 29, 2015
Accepted (ET)
Oct 1, 2015 · 7:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001011835
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 29, 2015 | A | 1,190 | $0.00 | A | 32,420 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $42.50 | Sep 30, 2015 | A | 2,380 | A | — | Sep 30, 2025 | Common Stock | 2,380 | 2,380 | D |
Explanation of responses
- F1Represents the grant of restricted stock units that vest 1/3 on each of 10/4/16, 10/4/17 and 10/4/18.
- F2The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) shall vest on September 30, 2016, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) shall vest on the first day of each full month thereafter.